Review article · 2013 · Open access
Targeting the PI3K-AKT-mTOR signaling network in cancer
癌症:英文版, 32(5), 253–265 · Published 5 May 2013 · DOI 10.5732/cjc.013.10057
In brief
“Targeting the PI3K-AKT-mTOR signaling network in cancer” is a 2013 review article by Khurum Hayat Khan and 3 co-authors, published in 癌症:英文版. OpenAlex counts 248 citations as of 21 November 2026. It is open access: the full text is free to read at 癌症:英文版.
- Citations
- 248
- Most cited in
- 2018 (28)
- Field-weighted impact
- 1.61
- References
- 79
- Authors
- 4
Abstract
The phosphoinositide 3-kinase-AKT-mammalian target of rapamycin (PI3K-AKT-mTOR) pathway is a frequently hyperactivated pathway in cancer and is important for tumor cell growth and survival. The development of targeted therapies against mTOR, a vital substrate along this pathway, led to the approval of allosteric inhibitors, including everolimus and temsirolimus, for the treatment of breast, renal, and pancreatic cancers. However, the suboptimal duration of response in unselected patients remains an unresolved issue. Numerous novel therapies against critical nodes of this pathway are therefore being actively investigated in the clinic in multiple tumor types. In this review, we focus on the progress of these agents in clinical development along with their biological rationale, the need of predictive biomarkers and various combination strategies, which will be useful in counteracting the mechanisms of resistance to this class of drugs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Khan, K. H., Yap, T. A., Li, Y., & Cunningham, D. (2013). Targeting the PI3K-AKT-mTOR signaling network in cancer. 癌症:英文版, 32(5), 253–265. https://doi.org/10.5732/cjc.013.10057
MLA 9
Khan, Khurum Hayat, et al. “Targeting the PI3K-AKT-mTOR signaling network in cancer.” 癌症:英文版, vol. 32, no. 5, 2013, pp. 253–265. https://doi.org/10.5732/cjc.013.10057.
Chicago
Khan, Khurum Hayat, Timothy Anthony Yap, Yan Li, and David Cunningham. 2013. “Targeting the PI3K-AKT-mTOR signaling network in cancer.” 癌症:英文版 32 (5): 253–265. https://doi.org/10.5732/cjc.013.10057.
Harvard
Khan, K. H. et al. (2013) ‘Targeting the PI3K-AKT-mTOR signaling network in cancer’, 癌症:英文版, 32(5), pp. 253–265. doi:10.5732/cjc.013.10057.
IEEE
K. H. Khan, T. A. Yap, Y. Li, and D. Cunningham, “Targeting the PI3K-AKT-mTOR signaling network in cancer,” 癌症:英文版, vol. 32, no. 5, pp. 253–265, 2013, doi: 10.5732/cjc.013.10057.
BibTeX
@article{khan2013targeting,
title = {{Targeting the PI3K-AKT-mTOR signaling network in cancer}},
author = {Khan, Khurum Hayat and Yap, Timothy Anthony and Li, Yan and Cunningham, David},
journal = {癌症:英文版},
year = {2013},
volume = {32},
number = {5},
pages = {253--265},
doi = {10.5732/cjc.013.10057},
url = {https://doi.org/10.5732/cjc.013.10057}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 10 | |
| 2018 | 28 | |
| 2019 | 19 | |
| 2020 | 24 | |
| 2021 | 23 | |
| 2022 | 20 | |
| 2023 | 11 | |
| 2024 | 17 | |
| 2025 | 15 | |
| 2026 | 19 |
Its field-weighted citation impact is 1.61: it has been cited 1.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR pathway
- mTOR inhibitors
- allosteric inhibitors
- everolimus
- temsirolimus
- targeted cancer therapy
- predictive biomarkers
- drug resistance
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Khan, K. H., Yap, T. A., Li, Y., & Cunningham, D. (2013). Targeting the PI3K-AKT-mTOR signaling network in cancer. 癌症:英文版, 32(5), 253–265. https://doi.org/10.5732/cjc.013.10057
How many times has this paper been cited?
248 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at 癌症:英文版: sign in and open the PDF from this page.
Who wrote this paper?
Khurum Hayat Khan, Timothy Anthony Yap, Yan Li, David Cunningham.
What is the DOI of this paper?
10.5732/cjc.013.10057, permanently at https://doi.org/10.5732/cjc.013.10057. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.